Search results
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 23 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the U.S. The drugmaker ...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
US FDA advisers to review Eli Lilly Alzheimer's drug
Reuters· 4 days agoBoth drugs are designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease. The antibody treatments, which...
Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down to $12.17
ETF DAILY NEWS· 2 days agoViridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report)’s share price gapped down before the market opened on Monday . Viridian Therapeutics shares last traded at $11.94, with a volume of ...
Analysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.33
ETF DAILY NEWS· 11 hours agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six research firms that are currently covering the firm, Marketbeat Ratings reports ...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Thomas Gad Sells 35,000 Shares
ETF DAILY NEWS· 2 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price ...
Head to Head Survey: Evaxion Biotech A/S (NASDAQ:EVAX) and Halozyme Therapeutics (NASDAQ:HALO)
ETF DAILY NEWS· 11 hours agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the ...
Ultragenyx executive sells over $440k in company stock By Investing.com
Investing.com· 2 days agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) has reported a significant stock transaction by one of...
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 10 hours agoTRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. Separately ...
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and...
KOLR - KSFX Ozarks· 1 day agoProtalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by ...